Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma

NCT03971539 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: BI 894416
DRUG: Placebo

Sponsor

Boehringer Ingelheim